Riskpilot← Back to searchSign inGet full accessTandläkare Degerman AB
ABActiveOrg 5590238225Corianders Allé 4Dental practice care activities · NACE 8623Est. 20155-9 employees
Revenue 2024
SEK 7,2M
+16% vs 2023
EBITDA margin
27.0%
+36% vs 2023
Equity ratio
58.8%
Financial strength
Net profit 2024
SEK 1,3M
+37% vs 2023
| Revenue | SEK 7,2M | +16% |
| EBITDA | SEK 2M | +36% |
| Net profit | SEK 1,3M | +37% |
| Total assets | SEK 3,2M | -24% |
| Equity | SEK 1,9M | +16% |
| Employees | — | — |
Legal name
Tandläkare Degerman AB
Org number
5590238225
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
24 augusti 2015
Share capital
SEK 50 000
Employees
5-9
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Aktiebolaget ska bedriva tandläkarpraktik samt äga och förvalta fast och lös egendom samt värdepapper samt idka därmed förenlig verksamhet.
Address
Corianders Allé 4
Email
ledning@tandlakaredegerman.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 767 | 7 563 | 8 199 | 6 263 | 7 245 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 735 | 1 842 | 2 190 | 1 444 | 1 959 |
| Depreciation & amort. | −904 | −920 | −1 004 | −583 | −373 |
| EBIT | 831 | 922 | 1 186 | 861 | 1 586 |
| Net financials | −83 | −65 | −36 | 11 | 3 |
| Profit before tax | 958 | 858 | 858 | 1 165 | 1 588 |
| Tax | −205 | −180 | −176 | −245 | −332 |
| Net profit | 753 | 678 | 682 | 920 | 1 256 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 502 | 5 186 | 3 962 | 4 277 | 3 238 |
| Equity | 1 368 | 2 045 | 1 727 | 1 647 | 1 903 |
| Long-term debt | 2 916 | 2 001 | 968 | 1 629 | 201 |
| Short-term debt | 1 219 | 1 140 | 974 | 1 002 | 1 135 |
| Total debt | 4 135 | 3 141 | 1 942 | 2 631 | 1 336 |
EBITDA margin
27.0%
This company
15.8%
Market median
+71% vs market
20202024
Equity ratio
58.8%
This company
38.2%
Market median
+54% vs market
20202024
Return on equity
66.0%
This company
18.4%
Market median
+259% vs market
20202024
Net profit margin
17.3%
This company
8.1%
Market median
+114% vs market
20202024
Asset turnover
2.24×
This company
1.12×
Market median
+100% vs market
20202024
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AC | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tandläkare Degerman AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Adam Carl Erik Eriksson Levd | Audit | 0 companies |
| Malin Margareta Degerman | Board of Directors | 0 companies |
| Bengt Gustaf Alfred Hildingsson | Deputy Board Member | 0 companies |
| Bengt Otto Johan Degerman | Chairman | 0 companies |